Inflammatory Bowel Disease

  • Philip F. Schofield
  • N. Y. Haboubi
  • D. F. Martin


Wilks and Moxon (1875)1 realised that there was an ulcerative condition of the colon which was non-infective. There was little progress in the management of ulcerative colitis over the next 59 years and in 1933, an article by Hardy and Bulmer2, about the natural history of the disease, indicated that one third of their patients died within a year of onset of the disease.


Inflammatory Bowel Disease Ulcerative Colitis Ileorectal Anastomosis Toxic Megacolon Ileoanal Anastomosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wilks S, Moxon W (1875) Lectures on pathological anatomy, 2nd edn. Churchill, LondonGoogle Scholar
  2. 2.
    Hardy TL, Bulmer E (1933) Ulcerative colitis. Br Med J ií: 812–815Google Scholar
  3. 3.
    Dalziel TK (1913) Chronic interstitial enteritis. Br Med J ii: 1068–1070Google Scholar
  4. 4.
    Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional enteritis: a pathological and clinical entity. JAMA 99: 1323–1329Google Scholar
  5. 5.
    Colp R (1934) A case of nonspecific granuloma of the terminal ileum and the cecum. Surg Clin North Am 14: 443–449Google Scholar
  6. 6.
    Lockhart-Mummery HE, Morson BC (1960) Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1: 87–105PubMedCrossRefGoogle Scholar
  7. 7.
    Lockhart-Mummery HE, Morson BC (1964) Crohn’s disease of the large intestine. Gut 5: 493–509PubMedCrossRefGoogle Scholar
  8. 8.
    Hawk WA, Turnbull RB, Farmer RG (1967) Regional enteritis of the colon. Distinctive features of the entity. JAMA 201: 738–746Google Scholar
  9. 9.
    Mendeloff AI (1975) The epidemiology of idiopathic inflammatory bowel disease. In: Inflammatory bowel disease. J.B. Kirsner, R.G. Shorter (eds). Lea and Febiger, Philadelphia pp 3–19Google Scholar
  10. 10.
    Price AB (1978) Overlap in the spectrum of non-specific inflammatory bowel disease — colitis indeterminate. J Clin Pathol 31: 567–577PubMedCrossRefGoogle Scholar
  11. 11.
    Shepherd NA (1991) Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 44: 726–733PubMedCrossRefGoogle Scholar
  12. 12.
    Beart RW (1988) Proctocolitis and ileoanal anastomosis. World J Surg 12: 160–163PubMedCrossRefGoogle Scholar
  13. 13.
    Sandler RS (1990) The epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 6: 531–535CrossRefGoogle Scholar
  14. 14.
    Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34: 1841–1854PubMedCrossRefGoogle Scholar
  15. 15.
    Jenkins D, Goodall A, Scott BB (1990) Ulcerative colitis: one disease or two? (Quantitative histological differences between distal and extensive disease.) Gut 31: 426–430PubMedGoogle Scholar
  16. 16.
    North CS, Clouse RE, Spitznagel EL, Alpers DH (1990) The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatr 147: 974–981PubMedGoogle Scholar
  17. 17.
    Roediger WEW (1990) The starved colon: diminished mucosal nutrition, diminished absorption and colitis. Dis Colon Rectum 33: 858–862PubMedCrossRefGoogle Scholar
  18. 18.
    Podolsky DK, Fournier DA (1988) Emergence of antigenic glycoprotein structures in ulcerative colitis detected through monoclonal antibodies. Gastroenterology 95: 371–378PubMedGoogle Scholar
  19. 19.
    Ramakrishna BS, Roberts-Thompson IC, Pannall PR, Roediger WEW (1991) Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. Gut 33: 46–49CrossRefGoogle Scholar
  20. 20.
    Gibson PR, Van de Pol E, Barratt PJ, Doe WF (1988) Ulcerative colitis — a disease characterised by the abnormal colonic epithelial cell. Gut 29: 516–521PubMedCrossRefGoogle Scholar
  21. 21.
    Hollander D, Vadheim CM, Brettholz E, Petersen M, Delahunty T, Rotter JI (1986) Increased intestinal permeability in patients with Crohn’s disease and their relatives. Ann Intern Med 105: 883–885PubMedGoogle Scholar
  22. 22.
    Katz KD, Hollander D, Vadheim CM et al., (1989) Intestinal permeability in patients with Crohn’s disease and their healthy relatives. Gastroenterology 97: 927–931PubMedGoogle Scholar
  23. 23.
    Zipser RD (1988) Introduction: mediators of inflammation in inflammatory bowel disease. Dig Dis Sci 33 (Suppl): 4S - 5SPubMedCrossRefGoogle Scholar
  24. 24.
    Thompson H, Bowser RS (1980) Granuloma, arteritis and inflammatory cell counts in Crohn’s disease. In: Developments in gastroenterology: recent advances in Crohn’s disease, vol 1. A.S. Pena et al. (eds). Martinus Nijhoff, Dordrecht, pp 80–83Google Scholar
  25. 25.
    Carr ND, Pullan BR, Schofield PF (1986) Microvascular studies in non-specific inflammatory bowel disease. Gut 27: 542–549PubMedCrossRefGoogle Scholar
  26. 26.
    Wakefield AJ, Sawyer AM, Dhillon AP et al. (1989) Pathogenesis of Crohn’s disease: multifocal gastrointestinal infarction. Lancet ii: 1057–1062Google Scholar
  27. 27.
    Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI (1989) Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 96: 1016–1020PubMedGoogle Scholar
  28. 28.
    Farmer RC (1989) Study of family history among patients with inflammatory bowel disease. Scand J Gastroenterol 24 (Suppl 170): 64–65CrossRefGoogle Scholar
  29. 29.
    Snook JA, De Silva HJ, Jewell DP (1989) The association of autoimmune disorders with inflammatory bowel disease. Q J Med 72: 835–840PubMedGoogle Scholar
  30. 30.
    Snook JA, Lowes JR, Wu KC, Priddle JD, Jewell DP (1991) Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis. Gut 32: 163–166PubMedCrossRefGoogle Scholar
  31. 31.
    Zeitz M (1990) Immunoregulatory abnormalities in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2: 246–250Google Scholar
  32. 32.
    Mahida Y (1990) Macrophage function in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2: 251–255Google Scholar
  33. 33.
    Tanaka K, Wilks M, Coates PJ, Farthing MJG, Walker-Smith JA, Tabaqchali S (1991) Mycobacterium paratuberculosis in Crohn’s disease. Gut 32: 43–45PubMedCrossRefGoogle Scholar
  34. 34.
    Mandal BK (1984) Differentiation of acute infective colitis and inflammatory bowel disease with coincident infection. Int Med Spec 3: 175–190Google Scholar
  35. 35.
    Schofield PF (1990) Inflammatory disease of the large bowel. Surgery 85: 2020–2026Google Scholar
  36. 36.
    Bartholomeusz FDL, Shearman DJC (1989) Measurement of activity in Crohn’s disease. J Gastroenterol Hepatol 4: 81–94PubMedCrossRefGoogle Scholar
  37. 37.
    Hodgson HJF, Mazlam MZ (1991) Review article: assessment of drug therapy in inflammatory bowel disease. Aliment Pharmacol Therap 5: 555–584CrossRefGoogle Scholar
  38. 38.
    Lorusso D, Leo S, Dimatteo G, Giorgio P, Caruso ML (1988) Evaluation of the extent of ulcerative colitis: comparison between colonoscopic and histologic assessment. Coloproctology 4: 212–214Google Scholar
  39. 39.
    Potzi R, Waifram M, Lochs H, Holzner H, Gangl A (1989) Diagnostic significance of endoscopic biopsy in Crohn’s disease. Endoscopy 21: 60–62PubMedCrossRefGoogle Scholar
  40. 40.
    Yao T, Okada M, Fuchigami T et al. (1989) The relationship between the radiological and clinical features in patients with Crohn’s disease. Clin Radiol 40: 389–392PubMedCrossRefGoogle Scholar
  41. 41.
    Balthazar EJ, Chako AC (1990) Computerized tomography in acute gastrointestinal disorders. Am J Gastroenterol 85: 1445–1452PubMedGoogle Scholar
  42. 42.
    Koelbel G, Schmiedl U, Majer MC et al. (1989) Diagnosis of fistula and sinus tracts in patients with Crohn’s disease: value of MR imaging. Am J Radiol 152: 999–1003Google Scholar
  43. 43.
    Crama-Bohbouth GE, Arndt JW, Pena AS et al. (1988) Value of indium-III granulocyte scintigraphy in the assessment of Crohn’s disease of the small intestine: prospective investigation. Digestion 40: 227–236PubMedCrossRefGoogle Scholar
  44. 44.
    Lumb G, Prothero RH, Ramsay GS (1955) Ulcerative colitis with dilatation of the colon. Br J Surg 43: 182–188PubMedCrossRefGoogle Scholar
  45. 45.
    Smith FW, Law DH, Nickel WF, Sleisenger MH (1962) Fulminant ulcerative colitis with toxic dilatation of the colon: medical and surgical management of 11 cases with observations regarding etiology. Gastroenterology 42: 233–243Google Scholar
  46. 46.
    McInerney GT, Sauer WG, Baggenstoss AH et al. (1962) Fulminating ulcerative colitis with marked dilatation. Gastroenterology 42: 244–257Google Scholar
  47. 47.
    Jalan KN, Sircus W, Card WI et al. (1969) An experience of ulcerative colitis. I. Toxic dilatation in 55 cases. Gastroenterology 57: 68–82PubMedGoogle Scholar
  48. 48.
    Grieco MB, Bordan DC, Geiss AC, Beil AR (1980) Toxic megacolon complicating Crohn’s disease. Ann Surg 191: 75–80PubMedCrossRefGoogle Scholar
  49. 49.
    Greenstein AJ, Sachar DB, Gibas A et al. (1985) Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol 7: 137–143PubMedCrossRefGoogle Scholar
  50. 50.
    Schofield PF, Mandal BK, Ironside AG (1979) Toxic dilatation of the colon in Salmonella colitis and inflammatory bowel disease. Br J Surg 66: 5–9PubMedCrossRefGoogle Scholar
  51. 51.
    Can ND, Wells S, Haboubi NY et al. (1986) Ischaemic dilatation of the colon. Ann R Coll Surg Engl 68: 264–266Google Scholar
  52. 52.
    Turnbull RB, Hawk WA, Schofield PF, Weakley F (1970) Choice of operation for the toxic megacolon phase of non-specific ulcerative colitis. Surg Clin North Am 50: 1151–1169PubMedGoogle Scholar
  53. 53.
    Goligher JC, Hoffman DC, de Dombal FT (1970) Surgical treatment of severe attacks of ulcerative colitis with special reference to the advantages of early operation. Br Med J iv: 703–706Google Scholar
  54. 54.
    Flatmark A, Fretheim G, Gjone E (1975) Early colectomy in severe ulcerative colitis. Scand J Gastroenterol 10: 427–431PubMedGoogle Scholar
  55. 55.
    Danovitch SH (1989) Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am 18: 73–82PubMedGoogle Scholar
  56. 56.
    Edwards EC, Truelove SC (1964) The course and prognosis of ulcerative colitis. III. Complications. Gut 5: 1–21Google Scholar
  57. 57.
    Schofield PF (1982) Toxic dilatation and perforation in inflammatory bowel disease. Ann R Coll Surg Engl 64: 318–320PubMedGoogle Scholar
  58. 58.
    Softley A, Clamp SE, Bouchier IA et al. (1988) Perforation of the intestine in inflammatory bowel disease: an OMGE survey. Scand J Gastroenterol 23 (Suppl 144): 24–26Google Scholar
  59. 59.
    Leu S-Y, Leonard MB, Beart RW, Dozois RR (1986) Psoas abscess: changing patterns of diagnosis and etiology. Dis Colon Rectum 29: 694–698PubMedCrossRefGoogle Scholar
  60. 60.
    Morson BC (1968) Pathology. In: Ulcerative colitis. J.C.Goligher et al. (eds). Baillière Tindall and Cassell, LondonGoogle Scholar
  61. 61.
    Pennington L, Hamilton SR, Bayless TM et al. (1980) Surgical management of ulcerative colitis. Ann Surg 192: 311–318PubMedCrossRefGoogle Scholar
  62. 62.
    Greenstein AJ, Kark AE, Dreiling DA (1975) Crohn’s disease of the colon. Am J Gastroenterol 6: 40–48Google Scholar
  63. 63.
    Bargen JS (1928) Chronic ulcerative colitis associated with malignant disease. Arch Surg 17: 561–576CrossRefGoogle Scholar
  64. 64.
    Slaney G, Brooke BN (1959) Cancer in ulcerative colitis. Lancet ií: 694–698Google Scholar
  65. 65.
    Endling NPG, Eklöf D (1961) Radiological findings and prognosis in ulcerative colitis. Acta Chir Scand 121: 299–308Google Scholar
  66. 66.
    de Dombal FT, Watts J McK, Watkinson G, Goligher JC (1966) Local complications of ulcerative colitis: stricture, pseudopolyposis and carcinoma of the colon and rectum. Br Med J i: 1442–1447Google Scholar
  67. 67.
    Kewenter J, Ahiman H, Hulten L (1978) Cancer risk in extensive ulcerative colitis. Ann Surg 188: 824–828PubMedCrossRefGoogle Scholar
  68. 68.
    Gyde SN, Prior P, Macartney JC et al. (1980) Malignancy in Crohn’s disease. Gut 21: 1024–1029PubMedCrossRefGoogle Scholar
  69. 69.
    Warren S, Sommers CS (1949) Pathogenesis of ulcerative colitis. Am J Pathol 25: 657–679PubMedGoogle Scholar
  70. 70.
    Morson BC, Pang LSC (1967) Rectal biopsies as an aid to cancer control in ulcerative colitis. Gut 8: 423–434PubMedCrossRefGoogle Scholar
  71. 71.
    Dickinson RI, Dixon MF, Axon AT (1980) Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet ii: 620–622Google Scholar
  72. 72.
    Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB (1977) Cancer in colitis: assessment of the individual risks by clinical and histological criteria. Gastroenterology 73: 1280–1289PubMedGoogle Scholar
  73. 73.
    Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF (1973) Crohn’s disease and cancer. N Engl J Med 289: 1099–1103PubMedCrossRefGoogle Scholar
  74. 74.
    Richards ME, Rickert RR, Nance FC (1989) Crohn’s disease-associated carcinoma: a poorly recognised complication of inflammatory bowel disease. Ann Surg 209: 764–773PubMedCrossRefGoogle Scholar
  75. 75.
    Korelitz BI, Lauwers GY, Sommers SC (1990) Rectal mucosal dysplasia in Crohn’s disease. Gut 31: 1382–1386PubMedCrossRefGoogle Scholar
  76. 76.
    Riddell R, Goldman H, Ransohoff DF et al. (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14: 931–968PubMedCrossRefGoogle Scholar
  77. 77.
    Filipe MI, Edwards MR, Ehsanullah M (1985) A prospective study of dysplasia and carcinoma in the rectal biopsies and rectal stump of 8 patients following ileorectal anastomosis in ulcerative colitis. Histopathology 9: 1139–1153PubMedCrossRefGoogle Scholar
  78. 78.
    Jones HW, Grogono J, Hoare AM (1988) Surveillance in ulcerative colitis: burdens and benefits. Gut 29: 325–331PubMedCrossRefGoogle Scholar
  79. 79.
    Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB (1990) Precancer and cancer in extensive ulcerative colitis: findings amongst 401 patients over 22 years. Gut 31: 800–806PubMedCrossRefGoogle Scholar
  80. 80.
    Isbell G, Levin B (1989) Ulcerative colitis and colonic cancer. Gastroenterol Clin North Am 17: 773–791Google Scholar
  81. 81.
    Wright V, Watkinson G (1965) 1. The arthritis of ulcerative colitis. 2. Sacro-iliitis and ulcerative colitis. Br Med J ii: 670–674, 675–680Google Scholar
  82. 82.
    Janowitz HD, Sachar DB (1976) New observations in Crohn’s disease. Ann Rev Med 27: 269–285CrossRefGoogle Scholar
  83. 83.
    Mallas EG, Mackintosh P, Asquith P, Cook WT (1976) Histocompatability antigens in inflammatory bowel disease. Gut 17: 906–910PubMedCrossRefGoogle Scholar
  84. 84.
    Hopkins DJ, Horan E, Burton IL et al. (1974) Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol 58: 732–737PubMedCrossRefGoogle Scholar
  85. 85.
    Coles RS (1982) Implications of uveitis and other extra-intestinal manifestations in inflammatory bowel disease. B. I. Korelitz (ed). John Wright, Bristol, pp 15–19Google Scholar
  86. 86.
    Thornton JR, Teague RH, Slow-Beer TS et al. (1980) Pyoderma gangrenosa and ulcerative colitis. Gut 21: 247–248PubMedCrossRefGoogle Scholar
  87. 87.
    Heaton KW, Read AE (1969) Gallstones in patients with disorders of the terminal ileum and distorted bile salt metabolism. Br Med J iil: 494–496Google Scholar
  88. 88.
    Eade MN, Cooke WT, Brooke BN (1970) Liver disease in ulcerative colitis. Ann Intern Med 72: 489–497PubMedGoogle Scholar
  89. 89.
    Dordal E, Glagov S, Kirsner JB (1967) Hepatic lesions in chronic inflammatory bowel disease. Gastroenterology 52: 239–252PubMedGoogle Scholar
  90. 90.
    Lupinetti M, Mehigan D, Cameron JL (1980) Hepatobiliary complications of ulcerative colitis. Am J Surg 139: 113–118PubMedCrossRefGoogle Scholar
  91. 91.
    Nemeth A, Ejderhamn J, Glaumann H, Strandvik B (1990) Liver damage in juvenile inflammatory bowel disease. Liver 10: 239–248PubMedGoogle Scholar
  92. 92.
    Parker RGF, Kendall EJC (1954) The liver in ulcerative colitis. Br Med J ii: 1030–1032Google Scholar
  93. 93.
    Chapman RW, Marborough BA, Rhodes JM et al. (1980) Primary sclerosing cholangitis. Gut 21: 870–877PubMedCrossRefGoogle Scholar
  94. 94.
    Thorpe ME, Scheuer PJ, Sherlock S (1967) Primary sclerosing cholangitis: the biliary tree and ulcerative colitis. Gut 8: 435–448PubMedCrossRefGoogle Scholar
  95. 95.
    Schofield PF, Staff WG, Moore T (1968) Ureteral involvement in regional ileitis ( Crohn’s disease ). J Urol 99: 412–416Google Scholar
  96. 96.
    Present DH, Rabinowitz JG, Banks PA et al. (1968) Obstructive hydronephrosis. N Engl J Med 280: 523–528CrossRefGoogle Scholar
  97. 97.
    Kyle J (1980) Urinary complications of Crohn’s disease. World J Surg 4: 153–160PubMedCrossRefGoogle Scholar
  98. 98.
    Deren JJ, Porush JG, Levitt MF et al. (1962) Nephrolithiasis as a complication of ulcerative colitis and regional enteritis. Ann Intern Med 56: 843–853PubMedGoogle Scholar
  99. 99.
    Lowdell CP, Shousha S, Parkins RA (1986) The incidence of amyloidosis complicating inflammatory bowel disease. A prospective study of 177 patients. Dis Colon Rectum 29: 351–354PubMedCrossRefGoogle Scholar
  100. 100.
    McCaffery TD, Khosrow N, Lawrence AM, Kirsner JB (1970) Severe growth retardation in children with inflammatory bowel disease. J Pediatr 45: 386–393Google Scholar
  101. 101.
    Kirschner BS (1990) Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand 366 (Suppl): 98–104CrossRefGoogle Scholar
  102. 102.
    Barton JR, Ferguson A (1990) Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med 277: 423–439Google Scholar
  103. 103.
    Davies G, Evans CM, Shand WS, Walker-Smith JA (1990) Surgery for Crohn’s disease in childhood: influence of disease and operative procedure on outcome. Br J Surg 77: 891–894PubMedCrossRefGoogle Scholar
  104. 104.
    Svartz N (1942) Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 110: 577–598CrossRefGoogle Scholar
  105. 105.
    Baron JH, Connell AM, Lennard-Jones JE, Jones F (1962) Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. Lancet i: 1094–1096Google Scholar
  106. 106.
    Summers RW, Switz DM, Sessions JT Jr et al. (1979) National co-operative Crohn’s disease study: results of drug treatment. Gastroenterology 77: 847–869PubMedGoogle Scholar
  107. 107.
    Malchow H, Ewe K, Brandes JW et al. (1984) European co-operative Crohn’s disease study: results of drug treatment. Gastroenterology 86: 249–266PubMedGoogle Scholar
  108. 108.
    Misiewicz JJ, Lenard-Jones JE, Connell AM, Baron JH, Avery-Jones F (1965) Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet i: 185–188Google Scholar
  109. 109.
    Azad Khan AK, Piris J, Truelove SC (1977) An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet ií: 892–895Google Scholar
  110. 110.
    Meyers S (1988) The place of oral 5-aminosalicylic acid in the therapy of ulcerative colitis. Am J Gastroenterol 83: 64–67PubMedGoogle Scholar
  111. 111.
    Laursen LS, Stokohn M, Bukhave K, Rask-Madsen J, Lauritsen K (1990) Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values and urinary excretion. Gut 31: 1271–1276CrossRefGoogle Scholar
  112. 112.
    Biddle WL, Miner PB Jr (1990) Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology 99: 113–118PubMedGoogle Scholar
  113. 113.
    Campieri M, De Franchis R, Porro GB, Ranzi T, Brunetti G, Barbara L (1990) Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis: a randomized controlled trial. Scand J Gastroenterol 25: 663–668PubMedCrossRefGoogle Scholar
  114. 114.
    Truelove SC, Witts LT (1955) Cortisone in ulcerative colitis, final report on a therapeutic trial. Br Med J ii: 1041–1048Google Scholar
  115. 115.
    Truelove SC (1958) Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium: a controlled trial employing restricted sequential analysis. Br Med J ií: 1072–1077Google Scholar
  116. 116.
    Truelove SC, Jewell DP (1974) Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet i: 1067–1070Google Scholar
  117. 117.
    Truelove SC (1988) Medical management of ulcerative colitis and indications for colectomy. World J Surg 12: 142–147PubMedCrossRefGoogle Scholar
  118. 118.
    Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pastemack BD (1980) Treatment of Crohn’s disease with 6-mercaptopurine. A long-term randomized, double-blind study. N Engl J Med 302: 981–987Google Scholar
  119. 119.
    Adler DJ, Korelitz BI (1990) The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol 85: 717–722PubMedGoogle Scholar
  120. 120.
    Lemann M, Bonhomme P, Bitoun A, Messing B, Mogliani R, Rambaud JC (1990) Treatment of Crohn’s disease with azathioprine or 6-mercaptopurine: retrospective study in 126 patients. Gastroenterol Clin Biol 14: 548–554PubMedGoogle Scholar
  121. 121.
    Allam BF, Tillman JE, Thomson TJ, Crossling FT, Gilbert LM (1987) Effective intravenous cyclosporin therapy in a patient with severe Crohn’s disease on parenteral nutrition. Gut 28: 1166–1169PubMedCrossRefGoogle Scholar
  122. 122.
    Lightner S, Present DH (1990) Preliminary report: cyclosporin in the treatment of severe active ulcerative colitis. Lancet 336: 16–19.CrossRefGoogle Scholar
  123. 123.
    Brynskov J, Freud L, Rasmussen SN et al. (1989) A placebo-controlled double-blind, randomized trial of cyclosporin therapy in active Crohn’s disease. N Engl J Med 321: 845–850PubMedCrossRefGoogle Scholar
  124. 124.
    Payne-James JJ, Silk DB (1988) Total parenteral nutrition as primary treatment in Crohn’s disease — RIP? Gut 29: 1304–1308PubMedCrossRefGoogle Scholar
  125. 125.
    Greenberg GR, Fleming CR, Jeejeebhoy KN, Rosenberg IH, Sales D, Tremaine WJ (1988) Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gut 29: 1309–1315PubMedCrossRefGoogle Scholar
  126. 126.
    O’Morain CA (1990) Does nutritional therapy in inflammatory bowel disease have a primary or an adjunctive role? Scand J Gastroenterol 25 (Suppl 172): 29–34CrossRefGoogle Scholar
  127. 127.
    Allan RN (1988) Medical management: its accomplishments in Crohn’s disease and indications for surgery. World J Surg 12: 174–179PubMedCrossRefGoogle Scholar
  128. 128.
    Bernstein LH, Frank MS, Brandt LJ, Boley SJ (1980) Healing of perianal Crohn’s disease with metronidazole. Gastroenterology 79: 357–365PubMedGoogle Scholar
  129. 129.
    Ursing B, Alm T, Baramy F et al. (1982) A comparative study of metronidazole and sulphasalazine for active Crohn’s disease. Gastroenterology 83: 550–562PubMedGoogle Scholar
  130. 130.
    Babb RR (1988) The use of metronidazole (Flagyl) in Crohn’s disease. J Clin Gastroenterol 10: 479–481PubMedCrossRefGoogle Scholar
  131. 131.
    Crile G Jr, Thomas CY (1951) Treatment of acute toxic ulcerative colitis by ileostomy and simultaneous colectomy. Gastroenterology 19: 58–68PubMedGoogle Scholar
  132. 132.
    Brooke BN (1952) The management of ileostomy. Lancet 11: 102–104CrossRefGoogle Scholar
  133. 133.
    Aylett SO (1960) Diffuse ulcerative colitis and its treatment by ileorectal anastomosis. Ann R Coll Surg Engl 27: 260–284PubMedGoogle Scholar
  134. 134.
    Goligher JC (1978) The surgical treatment of colitis: past, present and future. Ann R Coll Surg Engl 60: 258–260PubMedGoogle Scholar
  135. 135.
    Kock NG (1969) Intra-abdominal “reservoir” in patients with permanent ileostomy. Arch Surg 99: 223–231PubMedCrossRefGoogle Scholar
  136. 136.
    Kock NG (1973) Continent ileostomy. In: Progress in surgery. M. Allgower, S.E. Bergentz and R.Y. Carne (eds). Karger, BasleGoogle Scholar
  137. 137.
    Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J ii: 85–88Google Scholar
  138. 138.
    Utsunomiya J, Iwama T, Imajo M, Matsuo S, Sawai S, Yalgashi K (1980) Total colectomy, mucosal proctocolectomy and ileo-anal anastomosis. Dis Colon Rectum 23: 459–466PubMedCrossRefGoogle Scholar
  139. 139.
    Nicholls RJ (1987) Restorative procto-colectomy with various types of reservoir. World J Surg 11: 751–762PubMedCrossRefGoogle Scholar
  140. 140.
    Dozois RR (1985) Alternatives to conventional ileostomy. Year Book, ChicagoGoogle Scholar
  141. 141.
    Smith LE (1989) Surgical therapy in ulcerative colitis. Gastroenterol Clin North Am 18: 99–110PubMedGoogle Scholar
  142. 142.
    Danovitch SH (1989) Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am 18: 73–82PubMedGoogle Scholar
  143. 143.
    Keighley MRB, Kmiot W (1990) Surgical options in ulcerative colitis: role of ileo-anal anastomosis. Aust NZ J Surg 60: 835–848CrossRefGoogle Scholar
  144. 144.
    Curran FT, Hill GL (1990) Results of 50 ileoanal J pouch operations. Aust NZ J Surg 60: 579–583CrossRefGoogle Scholar
  145. 145.
    Johnston D, Holdsworth PJ, Nasmyth DG et al. (1987) Preservation of the entire anal canal in conservative proctocolectomy for ulcerative colitis: a pilot study comparing end-to-end ileo-anal anastomosis without mucosal resection with mucosal proctectomy and endo-anal anastomosis. Br J Surg 74: 940–944PubMedCrossRefGoogle Scholar
  146. 146.
    Brough WA, Schofield PF (1989) An improved technique of J pouch construction and ileoanal anastomosis. Br J Surg 76: 350–351Google Scholar
  147. 147.
    Smith LE, Orkin BA (1990) Physiology of the ileoanal anastomosis. Semin Colon Rect Surg 1: 118–127Google Scholar
  148. 148.
    Best WR, Becktel JM, Singleton JW, Kern F (1976) Development of a Crohn’s disease activity index. Gastroenterology 70: 439–444PubMedGoogle Scholar
  149. 149.
    Farmer RG, Hawk WA, Turnbull RB (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68: 627–635PubMedGoogle Scholar
  150. 150.
    Manson JM, Schofield PF (1986) Indications for and results of operation in inflammatory bowel disease. J R Soc Med 79: 593–595PubMedGoogle Scholar
  151. 151.
    Basu MK, Asquith P, Thompson RA et al. (1975) Oral manifestations of Crohn’s disease. Gut 16: 249–254CrossRefGoogle Scholar
  152. 152.
    Nugent FW, Roy MA (1989) Duodenal Crohn’s disease: analysis of 89 cases. Am J Gastroenterol 84: 249–254PubMedGoogle Scholar
  153. 153.
    Cohen Z (1989) Surgery in inflammatory bowel disease. Curr Opin Gastroenterol 5: 514–519CrossRefGoogle Scholar
  154. 154.
    Rutgeerts P, Geboes K, Ventrappen G, Beryls J, Kerremans R, Hide M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99: 956–963PubMedGoogle Scholar
  155. 155.
    Pennington L, Hamilton SR, Bayless TM, Cameron JL (1980) Surgical management of Crohn’s disease. Ann Surg 192: 311–318PubMedCrossRefGoogle Scholar
  156. 156.
    Hultén L (1988) Surgical treatment of Crohn’s disease of the small bowel or ileocaecum. World J Surg 12: 180–185PubMedCrossRefGoogle Scholar
  157. 157.
    Alexander-Williams J, Haynes IG (1985) Conservative operation for Crohn’s disease of the small bowel. World J Surg 9: 945–951PubMedCrossRefGoogle Scholar
  158. 158.
    Lee ECG, Papaioannou N (1982) Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl 64: 229–233PubMedGoogle Scholar
  159. 159.
    Katariya RN, Sood G, Rao PG, Rao PL (1977) Stricturoplasty for tubercular stricture of the gastrointestinal tract. Br J Surg 64: 496–498PubMedCrossRefGoogle Scholar
  160. 160.
    Dehn TC, Kettlewell MG, Mortensen NJ, Lee ECG, Jewel DP (1989) Ten-year experience of stricturoplasty or resection for obstructive Crohn’s disease. Br J Surg 76: 339–341PubMedCrossRefGoogle Scholar
  161. 161.
    Whelan RL, Wong WD, Goldberg SM, Rothenberger DA (1989) Synchronous bowel anastomoses. Dis Colon Rectum 32: 365–368PubMedCrossRefGoogle Scholar
  162. 162.
    Hill GL, Bourchier RG, Whitney GB (1988) Surgical and metabolic management of patients with external fistulas of the small intestine associated with Crohn’s disease. World J Surg 12: 191–197PubMedCrossRefGoogle Scholar
  163. 163.
    McNamara MJ, Fazio VW, Lavery IC, Weakley FL, Farmer RG (1990) Surgical treatment of enterovesical fistulas in Crohn’s disease. Dis Colon Rectum 33: 271–276PubMedCrossRefGoogle Scholar
  164. 164.
    Shivananda S, Hordijk ML, Pena AS, Mayberry JF (1989) Crohn’s disease: risk of recurrence and reoperation in a defined population. Gut 30: 990–995PubMedCrossRefGoogle Scholar
  165. 165.
    Schofield PF (1965) The natural history and treatment of Crohn’s disease. Ann R Coll Surg Eng136: 258–279Google Scholar
  166. 166.
    Andersson H, Filipson S, Hultén L (1978) Determination of the faecal excretion of labelled bile salts after intravenous administration of 14C-cholic acid. An evaluation of bile salt malabsorption before and after surgery in patients with Crohn’s disease. Scand J Gastroenterol 13: 249–255Google Scholar
  167. 167.
    Fazio VW (1986) Currently used surgical procedures for inflammatory bowel disease. In: Inflammatory bowel disease. F. T. de Dombal et al. (eds). Oxford University Press, Oxford, pp 523–578Google Scholar
  168. 168.
    Brough WA, Schofield PF (1991) The value of the rectus abdominis myocutaneous flap in the treatment of complex perineal fistula. Dis Colon Rectum 34: 148–150PubMedCrossRefGoogle Scholar
  169. 169.
    Goligher JC (1985) The long-term results of excisional surgery for primary and recurrent Crohn’s disease of the large bowel. Dis Colon Rectum 28: 51–55PubMedCrossRefGoogle Scholar
  170. 170.
    Harting H, Hegnhoj J, Rasmussen TN, Jamum S (1991) Fate of the rectum after colectomy and ileostomy for Crohn’s disease. Dis Colon Rectum 34: 931–935CrossRefGoogle Scholar
  171. 171.
    Ambrose NS, Keighley MR, Alexander-Williams J, Allan RN (1984) Clinical impact of colectomy and ileorectal anastomosis in the management of Crohn’s disease. Gut 25: 223–227PubMedCrossRefGoogle Scholar
  172. 172.
    Allan A, Andrews H, Hilton CJ, Keighley MRB, Allan RN, Alexander-Williams J (1989) Segmental colonic resection is an appropriate operation for short skip lesions due to Crohn’s disease in the colon. World J Surg 13: 611–616PubMedCrossRefGoogle Scholar
  173. 173.
    Gazzard BG (1987) The quality of life in Crohn’s disease. Gut 28: 378–381PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1993

Authors and Affiliations

  • Philip F. Schofield
    • 1
  • N. Y. Haboubi
    • 1
  • D. F. Martin
    • 1
  1. 1.University Hospital of South ManchesterManchesterUK

Personalised recommendations